P&K Skin Research Center Co. Ltd (347740) - Total Liabilities

Latest as of September 2025: ₩4.49 Billion KRW ≈ $3.04 Million USD

Based on the latest financial reports, P&K Skin Research Center Co. Ltd (347740) has total liabilities worth ₩4.49 Billion KRW (≈ $3.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

P&K Skin Research Center Co. Ltd - Total Liabilities Trend (2018–2024)

This chart illustrates how P&K Skin Research Center Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See P&K Skin Research Center Co. Ltd (347740) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

P&K Skin Research Center Co. Ltd Competitors by Total Liabilities

The table below lists competitors of P&K Skin Research Center Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
PTL LTD Ordinary Shares
NASDAQ:PTLE
USA $425.73K
Big Digital Energy, Inc.
NASDAQ:BGDE
USA $60.56 Million
Success Transformer Corporation Bhd
KLSE:7207
Malaysia RM72.80 Million
ABVC Biopharma Inc
NASDAQ:ABVC
USA $6.90 Million
Radiopharm Theranostics Limited American Depositary Shares
NASDAQ:RADX
USA $40.45 Million
Heerim Architects & Planners Co. Ltd
KQ:037440
Korea ₩116.90 Billion
Exxaro Tiles Limited
NSE:EXXARO
India Rs2.08 Billion
Greenland Hong Kong Holdings Limited
F:QFRA
Germany €93.77 Billion

Liability Composition Analysis (2018–2024)

This chart breaks down P&K Skin Research Center Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of P&K Skin Research Center Co. Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 13.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.05 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how P&K Skin Research Center Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for P&K Skin Research Center Co. Ltd (2018–2024)

The table below shows the annual total liabilities of P&K Skin Research Center Co. Ltd from 2018 to 2024.

Year Total Liabilities Change
2024-12-31 ₩5.10 Billion
≈ $3.46 Million
+61.14%
2023-12-31 ₩3.17 Billion
≈ $2.15 Million
-15.13%
2022-12-31 ₩3.73 Billion
≈ $2.53 Million
-7.31%
2021-12-31 ₩4.03 Billion
≈ $2.73 Million
-5.59%
2020-12-31 ₩4.27 Billion
≈ $2.89 Million
+22.85%
2019-12-31 ₩3.47 Billion
≈ $2.35 Million
+106.29%
2018-12-31 ₩1.68 Billion
≈ $1.14 Million
--

About P&K Skin Research Center Co. Ltd

KQ:347740 Korea Diagnostics & Research
Market Cap
$34.06 Million
₩50.25 Billion KRW
Market Cap Rank
#23301 Global
#1522 in Korea
Share Price
₩1740.00
Change (1 day)
-2.19%
52-Week Range
₩1740.00 - ₩3235.00
All Time High
₩7272.32
About

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vi… Read more